Skip Navigation
Skip to contents

KSC 2018

Program at a Glance

Home > Program > Program at a Glance
  • Scientific Session [Organon]
  • Evidence of Blood Pressure & Dyslipidemia Drugs for the Benefit of Cardiovascular Disease Patients
  • Apr. 21 (Fri.) 12:45-13:25, Rm.214
  • Chairperson: Jin Yong Hwang
12:45 - 13:00

How to Reach Target: Benefit of Atorvastatin Ezetimibe Combination

[Speaker] Jung Hyun Choi / Pusan National Univ., Korea

13:00 - 13:15

Importance of HTN Management with CV Disease and Evidence of Losartan

[Speaker] Jaewon Oh / Yonsei Univ., Korea

13:15 - 13:25

Discussion